Hormone sensitive prostate cancer Clinical Trials
Conditions / Hormone sensitive prostate cancer
Delta Trials indexes 15 clinical trials for Hormone sensitive prostate cancer in its publicly accessible dataset. Of these, 5 enrolling participants at this time and 1 trial have reached completion. This research takes place spanning 540 research sites around the world. An additional 9 trials are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
15
Total Trials
5
Recruiting
1
Completed
9
Other Active
0
Terminated since 2020
540
Study Locations
Browse by location (540 total)
- Montréal, Canada 4 trialsAll trials in Montréal, Canada
- Boston, United States 4 trialsAll trials in Boston, United States
- Montréal, Canada 4 trialsAll trials in Montréal, Canada
- Montréal, Canada 4 trialsAll trials in Montréal, Canada
- Petah Tikva, Israel 3 trialsAll trials in Petah Tikva, Israel
- Calgary, Canada 3 trialsAll trials in Calgary, Canada
- Barcelona, Spain 3 trialsAll trials in Barcelona, Spain
- Prešov, Slovakia 3 trialsAll trials in Prešov, Slovakia
- Orange, United States 3 trialsAll trials in Orange, United States
- Kaohsiung City, Taiwan 3 trialsAll trials in Kaohsiung City, Taiwan
- Seoul, South Korea 3 trialsAll trials in Seoul, South Korea
- Denver, United States 3 trialsAll trials in Denver, United States
- Trento, Italy 3 trialsAll trials in Trento, Italy
- Porto Alegre, Brazil 3 trialsAll trials in Porto Alegre, Brazil
- Vancouver, Canada 3 trialsAll trials in Vancouver, Canada
- Durham, United States 3 trialsAll trials in Durham, United States
- Petah-tikva, Israel 3 trialsAll trials in Petah-tikva, Israel
- Taichung, Taiwan 3 trialsAll trials in Taichung, Taiwan
- Villejuif, France 3 trialsAll trials in Villejuif, France
- Lancaster, United States 3 trialsAll trials in Lancaster, United States